24
Participants
Start Date
February 29, 2016
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
Bolus
A transversus abdominis catheter was inserted and ropivacaine 0.2% administered as two separate bolus doses of 24 mL each: one at time point zero and one 3 hours later.
Basal
A transversus abdominis catheter was inserted and ropivacaine 0.2% administered as a continuous basal infusion (8 mL/h) from time point zero for the following 6 hours.
Ucsd Ctri, La Jolla
Collaborators (1)
Zyno Medical
INDUSTRY
Teleflex
INDUSTRY
University of California, San Diego
OTHER